Application of protosappanin B in preparation of bladder cancer resistant perfusion fluid
A technology of hematoxylin and bladder cancer, applied in the application field of preparing anti-bladder cancer perfusion solution
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0010] Embodiment 1: The killing effect experiment of protohematoxylin B on bladder cancer cells is illustrated below in the pharmaceutical field:
[0011] 1. Experimental cells and drugs:
[0012] Cell lines: human bladder cancer cell line T24, purchased from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; mouse bladder cancer cell line BTT, gifted by Yang Xiaofeng, director of the Urology Department of the First Affiliated Hospital of Shanxi Medical University;
[0013] Protohematoxylin B: Prepare a liquid medicine with a concentration of 0.4% with water for injection, and sterilize it under high pressure;
[0014] Trypan blue staining solution.
[0015] 2. Experimental method:
[0016] (1) Digest, collect cells, and centrifuge at 1000rp / 5min. Human bladder cancer cell line T24 and mouse bladder cancer cell line BTT are respectively adjusted to 2× with water for injection. / ml.
[0017] (2) In the prohematoxylin B group, 500 μL of T24 cell susp...
Embodiment 2
[0022] Example 2: The tumor inhibitory effects of mitomycin and different doses of prohematoxylin B on T739 mice intraperitoneally inoculated with BTT cells were observed through the survival time of mice.
[0023] 1. Experimental materials
[0024] Experimental animals: 50 T739 mice, female, weighing 24-36 g; provided by the Animal Laboratory of Shanxi Cancer Institute, the production license number is SCXK (Jin) 2007-0001.
[0025] Experimental cells: mouse bladder cancer cell line BTT, donated by Prof. Yang Xiaofeng from Department of Urology, Shanxi Medical University.
[0026] Experimental drugs: mitomycin (commonly used anti-cancer western medicine), Zhejiang Hisun Pharmaceutical Co., Ltd., batch number 100401; prohematoxylin B: batch number: 20101010-2.
[0027] 2. Experimental method:
[0028] (1) Inoculation: Grind the BTT solid tumor under sterile conditions, make a cell suspension with normal saline, and adjust the concentration to 5×10 6 / ml, intraperitoneal ino...
Embodiment 3
[0040] 1. Experimental materials:
[0041] Experimental cells: Human bladder cancer T24 cell line was quoted from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. The T24 cell line was cultured in RPMI-1640 medium containing 10% fetal bovine serum. The cells in the logarithmic growth phase were selected for the experiment. They were digested with trypsin containing EDTA, and the cell viability was measured by the trypan blue exclusion method, and fused with PBS buffer. (phosphate buffered saline) to make a concentration of 1x / ml of cell suspension.
[0042] Experimental drug: prohematoxylin B, batch number: 20101010-2; mitomycin, a commonly used anticancer drug, produced by Zhejiang Hisun Pharmaceutical Co., Ltd., specification 2mg / bottle, production batch number: 110716.
[0043] Experimental animals: 60 female BALB / C nude mice, purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd., SPF grade, 7-9 weeks old, weighing 20g-22...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com